Drug Interactions: When initiating Mounjaro, consider reducing the dose of concomitantly administered insulin secretagogues (for instance sulfonylureas) or insulin to scale back the risk of hypoglycemia. In studies completed by Eli Lilly, the company of Mounjaro pens, most circumstances of most nausea, vomiting and diarrhoea happened when increasing the dose https://weightlosspharmaceutic.com/product/mounjaro-tirzepatide-injection-5mg-1-box-4-pens/